Travel & Tourism Industry release:
STOCKHOLM, May 18. 2018 /PRNewswire/ — This week, dosing was completed according to plan in the second clinical study with Immunose™ FLU, developed with the aim to become a modern and effective nasal influenza vaccine.
– In the perspective of this year’s severe influenza outburst we…
Click here to read the full release with contact information on PR Newswire. Some releases are not in English.
To post and circulate your own press release on FIR and the eTN Network please click here
Comments are closed here.